NXTC

NextCure (NXTC)

NextCure Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NXTC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/07	06:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports Full Year 2024 Financial Results	NASDAQ:NXTC	NextCure Inc
2025/02/15	03:40	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:NXTC	NextCure Inc
2025/02/07	06:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2025/02/04	08:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2025/02/04	08:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2025/02/04	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2025/01/10	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2025/01/10	22:05	GlobeNewswire Inc.	NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers	NASDAQ:NXTC	NextCure Inc
2024/12/10	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2024/12/10	22:05	GlobeNewswire Inc.	NextCure Announces Acceptance of IND Application for LNCB74	NASDAQ:NXTC	NextCure Inc
2024/12/05	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2024/11/26	21:00	GlobeNewswire Inc.	NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference	NASDAQ:NXTC	NextCure Inc
2024/11/19	22:05	GlobeNewswire Inc.	Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta	NASDAQ:NXTC	NextCure Inc
2024/11/15	08:59	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:NXTC	NextCure Inc
2024/11/08	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXTC	NextCure Inc
2024/11/08	06:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results	NASDAQ:NXTC	NextCure Inc
2024/11/06	06:05	GlobeNewswire Inc.	NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting	NASDAQ:NXTC	NextCure Inc
2024/10/04	22:05	GlobeNewswire Inc.	NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting	NASDAQ:NXTC	NextCure Inc
2024/09/16	21:05	GlobeNewswire Inc.	NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024	NASDAQ:NXTC	NextCure Inc
2024/08/02	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXTC	NextCure Inc
2024/08/02	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2024/08/02	05:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results	NASDAQ:NXTC	NextCure Inc
2024/06/21	05:10	GlobeNewswire Inc.	NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference	NASDAQ:NXTC	NextCure Inc
2024/06/19	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2024/05/31	05:05	GlobeNewswire Inc.	NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024	NASDAQ:NXTC	NextCure Inc
2024/05/03	05:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:NXTC	NextCure Inc
2024/04/25	05:05	GlobeNewswire Inc.	NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024	NASDAQ:NXTC	NextCure Inc
2024/04/08	20:00	GlobeNewswire Inc.	NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024	NASDAQ:NXTC	NextCure Inc
2024/04/04	20:05	GlobeNewswire Inc.	NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board	NASDAQ:NXTC	NextCure Inc
2024/04/02	20:00	GlobeNewswire Inc.	NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:NXTC	NextCure Inc